M.D. Ph.D. Hoyoung Huh - 02 Mar 2026 SCHEDULE 13G/A Report for Akari Therapeutics Plc Ordinary shares, $0.000000005 par value (AKTX)

Filing Manager: M.D. Ph.D. Hoyoung Huh
Reporting Manager: Hoyoung Huh, M.D., Ph.D.
Security: Akari Therapeutics Plc Ordinary shares, $0.000000005 par value
Symbol: AKTX
Shares outstanding: 98,911,400,364 shares
Disclosed Ownership: 18,199,697,667 shares
Ownership: 18%
Form type: SCHEDULE 13G/A
Filing time: 04 Mar 2026, 16:44:32 UTC
Date of event: 02 Mar 2026
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Hoyoung Huh, M.D., Ph.D.	18%	18,199,697,667	18,199,697,667	0	/s/ Hoyoung Huh, M.D., Ph.D.	Hoyoung Huh, Authorized Person